☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Mira Pharmaceuticals
Mira Pharmaceuticals Reports Preclinical Data of Ketamir-2 to Treat Depression
June 11, 2024
MIRA Pharmaceuticals & MIRALOGX Entered into an Exclusive Licensing Agreement for Ketamir-2
November 21, 2023
Load more...
Back to Home
